Request Demo
Last update 10 Jun 2025
HJ-787
Last update 10 Jun 2025
Overview
Basic Info
Drug Type Chemical drugs |
Synonyms HJ787 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with HJ-787CTR20242529
评价 HJ787 软膏在轻、中度特应性皮炎受试者中有效性和安全性的多中心、随机、双盲、安慰剂对照的Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of HJ787 ointment in subjects with mild to moderate atopic dermatitis
CTR20250633
评价HJ787软膏在寻常痤疮患者中有效性和安全性的Ⅱa期临床试验
[Translation] Phase IIa clinical trial to evaluate the efficacy and safety of HJ787 ointment in patients with acne vulgaris
CTR20242526
评价HJ787软膏在神经性皮炎受试者中有效性和安全性的多中心、随机、双盲、安慰剂对照的Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of HJ787 ointment in subjects with neurodermatitis
100 Clinical Results associated with HJ-787
Login to view more data
100 Translational Medicine associated with HJ-787
Login to view more data
100 Patents (Medical) associated with HJ-787
Login to view more data
100 Deals associated with HJ-787
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acne Vulgaris | Phase 2 | China | 25 Feb 2025 | |
| Mild Atopic Dermatitis | Phase 2 | China | 29 Jul 2024 | |
| Moderate Atopic Dermatitis | Phase 2 | China | 29 Jul 2024 | |
| Neurodermatitis | Phase 2 | China | 22 Jul 2024 | |
| Psoriasis | IND Approval | China | 26 Apr 2024 | |
| inflammatory dermatosis | IND Approval | China | 26 Sep 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free